APA (7th ed.) Citation

Schuurbiers, M. M. F., van Delft, F. A., Koffijberg, H., IJzerman, M. J., Monkhorst, K., Ligtenberg, M. J. L., . . . van den Heuvel, M. M. (2025). External validation of a serum tumor marker algorithm for early prediction of no durable benefit to immunotherapy in metastastic non-small cell lung carcinoma. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine, 47, 1. https://doi.org/10.1177/14230380251316788

Chicago Style (17th ed.) Citation

Schuurbiers, Milou M. F., Freek A. van Delft, Hendrik Koffijberg, Maarten J. IJzerman, Kim Monkhorst, Marjolijn J. L. Ligtenberg, Daan van den Broek, Huub H. van Rossum, and Michel M. van den Heuvel. "External Validation of a Serum Tumor Marker Algorithm for Early Prediction of No Durable Benefit to Immunotherapy in Metastastic Non-small Cell Lung Carcinoma." Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine 47 (2025): 1. https://doi.org/10.1177/14230380251316788.

MLA (9th ed.) Citation

Schuurbiers, Milou M. F., et al. "External Validation of a Serum Tumor Marker Algorithm for Early Prediction of No Durable Benefit to Immunotherapy in Metastastic Non-small Cell Lung Carcinoma." Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 47, 2025, p. 1, https://doi.org/10.1177/14230380251316788.